Home › Apatorsen added to first-line chemotherapy benefits metastatic bladder cancer patients
 

Keywords :   


Apatorsen added to first-line chemotherapy benefits metastatic bladder cancer patients

2015-06-02 17:19:37| Logistics - Topix.net

OncoGenex Pharmaceuticals, Inc. announced that results from an exploratory analysis of the Phase 2 Borealis-1 trial showed that metastatic bladder cancer patients with poor prognostic features benefited from apatorsen 600mg added to first-line chemotherapy compared to chemotherapy alone. Patients in the trial with a Karnofsky Performance Status of 80 percent or less, a common indicator of poor prognosis, experienced a 50 percent reduction in risk of death with the addition of apatorsen therapy .

Tags: added benefits cancer patients

Category:Transportation and Logistics

Latest from this category

All news
06.10Hurricane Milton Potential Storm Surge Flooding Map
06.10Hurricane Milton Probabilistic Storm Surge Graphics
06.10Hurricane Milton Graphics
06.10Hurricane Milton Forecast Discussion Number 6
06.10Summary for Hurricane Milton (AT4/AL142024)
06.10Hurricane Milton Public Advisory Number 6
06.10Hurricane Milton Wind Speed Probabilities Number 6
06.10Hurricane Kirk Graphics
Transportation and Logistics »
06.10Hurricane Milton Potential Storm Surge Flooding Map
06.10Hurricane Milton Probabilistic Storm Surge Graphics
06.10Hurricane Milton Graphics
06.10Hurricane Milton Forecast Discussion Number 6
06.10Hurricane Milton Wind Speed Probabilities Number 6
06.10Hurricane Milton Public Advisory Number 6
06.10Summary for Hurricane Milton (AT4/AL142024)
06.10Hurricane Kirk Graphics
More »